Stay updated on UNCOVER-2: Guselkumab Clinical Trial
Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.

Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check17 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.4%
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page has removed a specific clinical study reference regarding the efficacy and safety of switching to Ixekizumab in psoriasis treatment.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check60 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical study on ixekizumab for psoriasis, including detailed inclusion and exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference4%
Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.